TITLE

Aspirin Doesn't Guard Against Women's Heart Attacks

PUB. DATE
May 2005
SOURCE
Tufts University Health & Nutrition Letter;May2005, Vol. 23 Issue 3, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Presents findings of a study on the effect of aspirin on women's risk for heart attack, conducted by researchers at Brigham and Women's Hospital in Boston, Massachusetts. Association between aspirin and lowered heart-attack risk; Comparison of women in aspirin regimen with those in placebo; Side effects of taking aspirin in women.
ACCESSION #
16884035

 

Related Articles

  • Take an Aspirin and …. Buring, Julie; Ferrari, Nancy // Bulletin with Newsweek;4/25/2006, Vol. 124 Issue 6517, p46 

    The article presents information on aspirin, a wonder drug which provides effective pain relief. At low doses, it reduces the blood's ability to clot by inhibiting the action of tiny blood cells called platelets. It makes sense, then, that aspirin might help prevent clot- related cardiovascular...

  • What to Know About Aspirin Therapy.  // National Women's Health Report;Feb2005, Vol. 27 Issue 1, p5 

    Provides information about aspirin therapy in the U.S. Connection between aspirin and heart attack prevention; Risk of gastrointestinal bleeding in taking aspirin; Recommendation for people at high risk for heart attack or stroke to take aspirin.

  • A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease. Lamotte, Mark; Annemans, Lieven; Evers, Thomas; Kubin, Maria // PharmacoEconomics;2006, Vol. 24 Issue 2, p155 

    Background: Low-dose aspirin (acetylsalicylic acid) is standard care in patients with a history of cardiovascular disease (CVD). The use of low-dose aspirin in primary prevention is not yet fully established, although meta-analyses and US and European guidelines support its use in...

  • Rebound risk Aspirin and statin withdrawal.  // Consumer Reports;Aug2005, Vol. 70 Issue 8, p48 

    Reports on the results of a study that suggests that stopping daily low-dose aspirin or other heart-protective drugs can sharply increase your risk of heart attack and stroke. Description of the study; How stopping aspirin intake eliminates its protective benefits and may elevate risk beyond...

  • Aspirin + clopidogrel better for short-term outcomes in acute Ml.  // Journal of Family Practice;Feb2006, Vol. 55 Issue 2, p98 

    The article cites a study pertaining to the safety and efficacy of aspirin and clopidogrel combination on patients with acute myocardial infarction. In this study, more than 45,000 patients in Chinese hospitals are involved. Within onset of the symptoms, the patients were randomly selected and...

  • Triflusal: A Review of its Use in Cerebral Infarction and Myocardial Infarction, and as Thromboprophylaxis in Atrial Fibrillation. Murdoch, David; Plosker, Greg L. // Drugs;2006, Vol. 66 Issue 5, p671 

    Triflusal (Aflen®, Disgren®, Tecnosal®, Triflux®) is a novel platelet antiaggregant with structural similarities to salicylates, but which is not derived from aspirin. It has similar efficacy to aspirin in patients with cerebral or myocardial infarction, but has a reduced risk of...

  • Nonaspirin NSAIDs do not significantly alter risk of acute MI.  // Reactions Weekly;7/17/2004, Issue 1010, p3 

    Discusses research being done on nonsteroidal antiinflammatory drugs (NSAID) and the risk of myocardial infarction (MI). Reference to a study by L. A. Garcia Rodriguez et al, published in the June 2004 issue of "Circulation"; Assessment of the association of the drugs with reduction in MI;...

  • FACT OR FICTION.  // Newsweek (Atlantic Edition);10/30/2006 (Atlantic Edition), Vol. 148 Issue 18, p8 

    This article discusses the effects of aspirin on the stomach and upper digestive tract. Baby aspirin, or 1/4 of an adult tablet, may reduce the risk of heart attack, but a study reveals that aspirin my also be harmful towards the stomach. Researchers found that daily low-dose aspirin doubles...

  • Do NSAIDs inhibit the cardioprotective effects of ASA? Singh, Sheldon M.; Alter, David A. // CMAJ: Canadian Medical Association Journal;3/30/2004, Vol. 170 Issue 7, p1094 

    Focuses on a study on the clinical benefits of nonsteroidal anti inflammatory drugs (NSAID) and aspirin for the secondary prevention of coronary artery disease. Association on the use of NSAID on the risk of myocardial infarction; Limitations of the study; Result of the regular use of NSAID.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics